Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Inspire Medical Systems stock has a consensus rating of "Hold" and an average price target of $53.33. The average 1-year stock price forecast is 21.61% higher than the current stock price, while the lowest is $45 (+2.61%) and the highest is $65 (+48.22%).

Price Target: $53.33 (+21.61%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$45	$53.33	$53.5	$65
Change	+2.61%	+21.61%	+21.99%	+48.22%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	2	2	2	2
Buy	7	6	4	4	4	2
Hold	6	7	10	10	10	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	16	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Suraj Kalia Oppenheimer	Oppenheimer	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 7, 2026
Robbie Marcus JP Morgan	JP Morgan	Hold Maintains $67 → $54	Hold	Maintains	$67 → $54	+23.13%	May 5, 2026
Adam Maeder Piper Sandler	Piper Sandler	Buy → Hold Downgrades $85 → $55	Buy → Hold	Downgrades	$85 → $55	+25.41%	May 5, 2026
Jonathan Block Stifel	Stifel	Strong Buy Maintains $70 → $65	Strong Buy	Maintains	$70 → $65	+48.22%	May 5, 2026
Shagun Singh RBC Capital	RBC Capital	Hold Maintains $56 → $45	Hold	Maintains	$56 → $45	+2.61%	May 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

878.14M

Decreased by -3.71%

from 911.98M

Revenue Next Year

924.67M

Increased by 5.30%

from 878.14M

EPS This Year

1.42

Decreased by -70.87%

from 4.89

EPS Next Year

1.61

Increased by 12.89%

from 1.42

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	233.39M	407.86M	624.80M	802.80M	911.98M	878.14M	924.67M
Revenue Growth	102.28%	74.75%	53.19%	28.49%	13.60%	-3.71%	5.30%
EPS	-1.54	-1.60	-0.72	1.75	4.89	1.42	1.61
EPS Growth	-	-	-	-	179.43%	-70.87%	12.89%
Forward PE	-	-	-	-	-	30.79	27.28
No. Analysts	-	-	-	-	-	19	19

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	1.0B	1.1B
Avg	878.1M	924.7M
Low	815.4M	816.3M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	12.7%	29.3%
Avg	-3.7%	5.3%
Low	-10.6%	-7.0%

EPS Forecast

EPS	2026	2027	2028	2029	2030	2031
High	2.34	2.74
Avg	1.42	1.61
Low	-0.12	0.83

EPS Growth

EPS Growth	2026	2027	2028	2029	2030	2031
High	-52.1%	92.4%
Avg	-70.9%	12.9%
Low	-	-41.5%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.